Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Tuesday, June 30

OSTR S T

21181 Semiquantitative analysis of TNF-a mRNA by competitive RT-PCR in
PBMC of HIV-infected patients
Markus Altfeld*; J. Rockstroh; EL. Dumoulin; M.M. Addo; K. Schliefer;
A. Theisen; U. Spengler, Germany
21182 HIV-infection altersT cell immune response to hepatitis C virus antigens
Raiwer Peter Woitas*; J.K. Rockstroh; A. Theisen; U. Spengler, Germany
21183 CD30 and Rantes are potential correlates of HIV disease progression
Priscilla Biswas*; B. Mantelli; F. Veglia; A. Puglisi; A. Lazzarin; F. Delfanti;
G. Poli, Italy
21184 Cytokine and chemokine assays forlL-2, IFNy,TNFu, and RANTES, using
whole blood are equivalent to the PBMC-based assay
Janet Lathey*; R. Trout; B. Roberts; S.A. Spector, USA
21185 Human rlL-16 exerts potent HIV suppressing activity in acutely
infected-reservoir cells
Marie-Jose Truong*; E.C.A. Darcissac; E. Hermann; J. Dewulf; A. Capron;
G.M. Bahr, France
21186 Factors defining speed of HIV-infection progress
Lioudmila Siziakind*; Andrei Shemshurd; J. V. Shestakova, Russia
21187 Changes in serum interleukin-16 (IL-16) levels during the course of
HIV1 infection
Edith Darcissac*; C Amiel; Y. Mouton; M.R.A. Loyens; A. Capron; G.M.
Bahr, France
21188 Production of monokines in peripheral blood mononuclear cells of the
patients infected with human immunodeficiency virus
Masahiko Ito*; Limin He; H. Terunuma; R. Yang; F. Tanabe; H. Hanafusa;
N. Chiba; A. Iwamotp, Japan
21189 Regulation of macrophage inflammatory protein 1 ca (MIP1 a() in
mononuclear cells by mycobacterium tuberculosis during active
pulmonary tuberculosis infection
Harriet Mayanja-Kizza, Uganda
21190 The associations between production of chemotactic cytokines and
immune function in children with HIV
Adriana Rosca*; R. Costa, Romania
21191 Levels of IL-2 and slL-2R in lymphocyte cultures from patients receiving
antiretroviral therapy
Velislava Terzieva*;S.H. Raleva; L.Z. Froloshka; R.K. Markova, Bulgaria
21192 CD8+CTL induced in AIDS vaccine evaluation group phase I trials using
canarypox vectors (ALVAC) encoding multiple HIV gene products
(vCP125, vCP205, vCP300) given with or whitout subunit boost
Thomas Evans*;L. Corey; M.L. Clements-Mann; K. Weinhold; R.B. Belshe;
J.L. Excler; A.M. Duliege, USA
21193 A polytope vaccine strategy for the co-delivery of multiple HIV CD8+
cytotoxic T cells epitopes
Andreas Suhrbier*; S.A. Thomson; S.L. Elliot;]. Gardner; T. Woodberry;
L. Mateo, Australia
21194 Potent neutralization of primary HIV-1 isolates by antisera induced
upon immunization with a recombinant protein expressing the native
V1/V2 domain of gpl20
Abraham Pinter*; O. Trochev; W.J. Honnen;Z. Wu; S. Reiken; M. Lewis;
S.C Kayman, USA

21195 CD86 confers and directs and MHC class I restricted CTL induction
Michael Agadjanyan*; Kim; Weiner, USA

21196 Multi-subtype envelope-based DNA and protein immunization strategies
for broadening immune responses to HIV-1
Susan W. Barnett*; Y. Sun; H.S. Legg; T.C. VanCott; J.R. Mascola;
F.M. Sinangil, USA
21197 The effect of HIV specific immunization in subjects with other subtype
HIV-1 infection in Thailand: One year interim report
Vina Churdboonchart*;A. Limsuwan; R. Moss; W. Sirawaraporn;
B. Smutharaks; R. Sutthent; R. Trauger, Thailand
21198 Protective T-cell mediated immunity induced by a consecutive HIV-1
DNA and avipox vaccine regimen
Stephen Kent*;A. Zhao; E.M. Dax;J.D. Chandler; H.L. Robinson; D.B. Boyle;
I.A. Ramshaw, Australia
21199 A phase I trial of vaccinia-env/gag/pol (TBC-3B) given by alternative
routes, boosted with rgpl20.
Michael C Keefer*; M. McElrath; K. Weinhold; G.J. Gorse; M. Mulligan; D.
Francis; D. Panicali, USA
21200 Recombinant vaccine-induced protection against the highly pathogenic
SIVmac251 dependence on route of challenge exposure
Geneoveffa Franchini, USA
21201 HIV-1 cross-clade lymphoproliferative responses following
immunization with recombinant Gp120 SF2
Thippawan Chuenchitra*; S. Ratto-Kim; M. De Souza;
K. Rungruengthanakit; S. Nitayaphan; C Khamboonruang; C Chuenchitra;
R.A. Michael; F. Sinangil; A.M. Duliege; J.G. McNeil; D.L. Birx, Thailand
21202 HIV protective effect of HLA-A28 in Africans exists also in caucasians:
Analysis of the HLA-A28 antigen encoding alleles by sequence-based
typing (SBT)
Rudolf Wank*; Barbara Laumbacher, Germany
21203 Tissue distribution and fate of HIV-1 DNA vaccine in BALB/c mice
Kenji Okuda*; S.K. Kawamoto;J.F. Fukushima; Y.K. Koizumi;
B. W. Wahren; K.H. Hamajima; K.N. Nishioka, Japan
21204 Antigenicity of HIV-1-like Gag-V3 chimeric particles expressed by a
recombinant vaccinia virus system
Asato Kojima*; Atsushi Yasuda; E. Moriishi; T. Kurata; A. Kojima, Japan
21205 Improvement of nucleic acid vaccination against HIV-1 toward strong
systemic and mucosal immunity
Shin Sasaki*; K.H. Hamajima; J.F Fukushima; N.I. Ishii; H.M. Mohri;
K.O. Okuda, Japan
NOTES

IUN

CONFERENCE WORKBOOK

81